Skip to main content
. Author manuscript; available in PMC: 2013 Dec 11.
Published in final edited form as: Urology. 2008 Aug 9;72(4):10.1016/j.urology.2008.05.032. doi: 10.1016/j.urology.2008.05.032

Table 2. Response and survival (n = 25).

Endpoint n (%) 90% CI
Complete response 0 (0%) 0.00-0.11
Stable disease 10 (40%) 0.25-0.58
Progression 7 (28%) 0.16-0.46
Nonevaluable 6 (24%) 0.11-0.42
Time to progression Median 1.7 mon 1.6-3.5 mon
Overall surivival Median 11.1 mon 2.2-14.8 mon

CI = confidence interval.